C

Cellebrite DI

CLBT · NASDAQ · Technology

$11.50

$0.06 (-0.52%) today

Loading live data...

Market Cap

$2.89B

24h Volume

$39.6M

P/E Ratio

50.0

52w High

$19.56

52w Low

$10.44

Est. AI Revenue

25%

Loading chart data...

7-Day Sparkline (Static)

Company facts

CEO: Shiven Ramji
Founded: 1999
HQ: Petah Tikva, Israel
Employees: 1,285

Performance

24 Hours-0.52%
7 Days+2.22%
30 Days+4.07%
1 Year-37.70%

About Cellebrite DI

Cellebrite DI sells digital intelligence software to law enforcement and government agencies. Investigators use its tools to lawfully extract data from phones and devices, then analyze that evidence to build cases. Revenue comes from software licenses and subscriptions to those agencies.

AI accelerates the investigative work: Cellebrite AI and UFED AI help extract and surface relevant evidence from devices, Pathfinder analytics connects people, places, and events across large data sets, and digital forensics AI cuts the manual review burden on investigators.

Founded in 1999 and headquartered in Petah Tikva, Israel, Cellebrite trades on the NASDAQ, is led by CEO Thomas E. Hogan, and employs roughly 1,300 people.

Cellebrite DI in the AI buildout

Cellebrite sits in the Defense & Aerospace AI layer, applying AI to digital forensics rather than supplying the buildout. Its models speed up evidence extraction and analysis, which supports pricing and keeps agencies renewing. But the business rests on government forensics budgets, not on AI infrastructure demand. Supercycle scores its exposure as moderate: AI is a genuine product advantage inside a government software business.

CLBT is tracked in Defense & Aerospace AI, rated Peripheral on the AI Exposure leaderboard.

By the numbers

52-week range

CLBT trades at $11.50, 12% of the way up its 52-week range of $10.44 to $19.56.

Market cap

Market capitalization is $2.89B, with an AI Exposure Score of 25 out of 100.

Valuation vs peers

Its P/E ratio of 50.0 is above the Defense & Aerospace AI category median of 30.2.

Next earnings

Cellebrite DI is next expected to report earnings on November 11, 2026.

Market data as of the close on . Prices are end of day, not live.

Frequently asked questions

What does Cellebrite do?

Cellebrite sells digital forensics and investigative analytics software to law enforcement. Agencies use it to lawfully extract data from devices and analyze evidence in investigations.

How is Cellebrite exposed to AI?

Through product capability. AI accelerates evidence extraction and analysis, supporting pricing and renewals, but government forensics budgets drive revenue. Supercycle gives it an AI Exposure Score of 25 out of 100.

What are Cellebrite's main products?

Cellebrite AI, UFED AI for device data extraction, Pathfinder investigative analytics, and digital forensics AI tools.

Who leads Cellebrite and where is it based?

CEO Thomas E. Hogan leads Cellebrite from Petah Tikva, Israel. The company was founded in 1999, trades on the NASDAQ, and employs roughly 1,300 people.

Is CLBT a pure play AI stock?

No. Cellebrite is a government forensics software company that uses AI to speed investigations. Its score of 25 out of 100 reflects moderate, product-level AI exposure.

Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.